The Nitazene Response Act directs the Secretary of Health and Human Services to develop and publish evidence-based clinical guidelines for responding to nitazene overdoses, a growing public health concern involving ultra-potent synthetic opioids. The guidelines must include best practices for administering naloxone (an overdose reversal drug), specific guidance for emergency departments and hospitals, and tailored recommendations for rural and volunteer emergency medical services. The Secretary must publish these guidelines within 180 days of the bill's enactment and submit a report to Congress within one year explaining how the guidelines will help address nitazene overdose problems. The bill does not authorize specific funding but rather requires the federal health agency to develop and disseminate this critical guidance to healthcare providers and emergency responders across the country who may encounter nitazene overdoses.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.